We describe two adult cases of neurologic complications occurring after influenza vaccination. The first case was a 62-year-old man who experienced convulsions 5 days after vaccination, and the second case was a 70-year-old man who exhibited paraplegia 7 days after vaccination. Diagnoses of acute disseminated encephalomyelitis and transverse myelitis with acute motor axonal neuropathy were made, respectively, and steroid pulse therapy and intravenous gammaglobulin therapy alleviated the patients' symptoms. Although the efficacy and cost benefit of influenza vaccination have been widely accepted, such neurologic complications might occur in the elderly or even in adults. (Internal Medicine 42: 191-194, 2003) 
Introduction
Guillain-Barre syndrome (GBS) and acute disseminated encephalomyelitis (ADEM) are thought to be major neurologic complications after infection or vaccination caused mainly by a T-cell-mediated immune reaction to myelin components or oligodendrocytes (1) (2) (3) . Here, we report two cases of early-elderly patients who suffered from neurologic complications after influenza vaccinations. Adult cases have been reported only rarely (2) .
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Case Reports
Patient 1 was a 62-year-old man who had been diagnosed with type-C liver cirrhosis, for which he had been admitted to our hospital once or twice per year for treatment. Five days after an influenza vaccination (HA type, 22-7-B) administered by a home doctor on November 20, 2001, generalized convulsion occurred and the patient was admitted to our hospital. He was intubated transiently in the emergency room because of respiratory failure. Myoclonic movement was found on the left side of his face when he was transferred to a neurological ward. There was no apparent paresis.
His reflexes were generally hyperactive, and pseudobulbar palsy and dysuria were noted. Laboratory analyses revealed liver dysfunction and a serum ammonium concentration of 237 jul/dl. There was no significant inflammatory reaction and antibodies for the influenza virus in paired sera were not significantly elevated. A lumbar tap revealed a pressure of 140 mmH20, and cerebrospinal fluid examination revealed a protein concentration of 280 mg/dl, five cells per microliter, and an IgG concentration of 101 LXg/ml. MRdiffusion-and T2-weighted images exhibited high signal intensities in midbrain, bilateral occipital cortices, right insular cortex, temporal operculum, inferior frontal gyms, and left frontal white matter (Fig. 1) . Although MRimages obtained 3 weeks after admission showedno abnormalities in the spinal cord, the patient presented bladder dysfunction and thus we diagnosed him as having ADEM.The left facial myoclonus disappeared after daily intravenous administration of 1 ,000-mg methylprednisolone for 3 days. The same dosage was administered again one week later, and the pseudobulbar palsy was ameliorated. Onemonthlater the dysuria also wasalleviated. At that time the abnormal-intensity lesion in MRIdisappeared. Serum ammoniumlevel decreased to around 150 ixl/dl by administration of branched amino acid and he was discharged without any sequelae. matic arthritis and diabetes mellitus. His homedoctor had controlled both diseases and the severity was mild. Backache followed by dysuria and paraplegia appeared 7 days after an influenza vaccination administered by his home doctor on November 4, 2000. The cranial nerves were normal, but right lower-dominant paraplegia and distal upper-limb motor pareses were noted. The right patella tendon reflex was hyperactive, but other reflexes were reduced. Below the nipple level all sensation modalities were suppressed. Laboratory analyses revealed an increased lymphocyte CD4/CD8 ratio, and anti-GMl antibodies were detected in his serum. An antibody titer for the influenza virus was unremarkable for paired sera. An antinuclear antibody was negative. RAmeasured 503 IU/ml. The serum HbAlc concentration was 7.3%. Although there was neither pleocytosis nor elevated protein concentration in the cerebrospinal fluid, the amplitude and, to a lesser extent, the velocity of the muscle compoundaction potentials were reduced (Table 1) , which suggested acute motor axonal neuropathy. Follow-up data obtained 1 month later showed only partial recovery in the amplitude of muscle compoundaction potentials. Sensory evoked potentials induced by mediannerve stimulation were almost normal, but tibial nerve stimulation did not evoke a response. A spinal MRT2-weighted image exhibited a high signal intensity in C6-T3 vertebral level ( Fig. 2A ). Brain MRI showed only lacunar infarction. A daily dose of 1,000-mg methylprednisolone was administered for 3 days, followed by 60 mg of prednisolone per day, which was gradually reduced.
Because of poor response to steroid therapy and symptom similarity to Guillain-Barre-type neuropathy, plasma exchange was performed but was not effective. A high dose of gammaglobulin (0.5g/kg body weight) was administered Table 1 2B ), but although the patient showed partial recovery, he was still unable to walk unaided after 10 months. The serum HbAlc concentration was reduced to 6.4% by diet when he was discharged.
Discussion
In our case 1, hyperammonium was present but such focal lesions were usually not found in the central nervous system -we therefore concluded that the lesions were caused by ADEM. The cerebrospinal fluid was not reanalyzed at the follow-up because of rapid reduction of symptoms. In case 2 the CSFfindings were normal at admission, perhaps because of the examination being performed too early, and unfortunately there was no follow-up data. Although the patient had diabetes mellitus, its severity was too mild to cause polyneuropathy. Spinal MRI findings, the nerve-conduction study, and the presence of anti-GMl antibodies in the patient's serum strongly suggested acute myeloneuropathy caused by an allergic reaction. The occurrence of complications following influenza vaccination decreased after the introduction of the HAtype of influenza vaccine in 1972 in Japan, but up to 1996 around 70 cases with neurologic complications had been reported (3). ADEM and myelitis constituted eight and two of these cases, respectively, and all were children. GBSwas reported in 16 cases, but all of the cases maynot have been related to the vaccination because some cases had prodromal infection. The present report is important because both cases were adults (i.e., early-elderly subjects). reports of an axonal-type GBSwith anti-GMl antibodies in the patient's serum, but these had not occurred after vaccina- Concerning the treatment, steroid pulse therapy was effective in patient 1 whereas neither steroid treatment nor plasma exchanges were effective in patient 2, but intravenous gammaglobulin showed mild efficacy in the latter patient. Because of the rarity of this disease with only a few cases reported in the literature, no treatment regimen has been established. In patients with multiple sclerosis the exacerbation rate following influenza illness is significantly higher than that after vaccination, and hence an annual influenza vaccination should be offered routinely to all patients with relapsing multiple sclerosis (8). Govaert et al reported the efficacy of influenza vaccination in elderly individuals in a randomized double-blind placebo-controlled trial (9), and Nichol et al proved the efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community (10). Postinfectious encephalitis, myelitis, and GBS have also been reported after influenza virus infection. Therefore, the rare occurrence of the complications and the possibility of neurologic complications after influenza infection should not discourage us against vaccination. Even though adult cases with ADEM or myelitis after influenza vaccination are rare, if a person shows some neurologic signs after the vaccination the home doctor should still refer the patient to a neurologist as soon as possible. Further epidemiological surveillance for complications and the effectiveness of influenza vaccinations might be worthwhile in Japan.
